Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
  • Domingo-Domenech, Eva
  • Pro, Barbara
  • Illidge, Tim
  • Horwitz, Steven
  • Trumper, Lorenz
  • ... Kim, Won-Seog
  • 외 21명
Citations

WEB OF SCIENCE

4
Citations

SCOPUS

4

키워드

CD30 EXPRESSIONDISEASEADULTS
제목
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
저자
Domingo-Domenech, EvaPro, BarbaraIllidge, TimHorwitz, StevenTrumper, LorenzIyer, SwamiAdvani, RanjanaBartlett, Nancy L.Christensen, Jacob HaaberKim, Won-SeogFeldman, TatyanaChoi, IlseungGritti, GiuseppeBelada, DavidShustov, AndreiIlles, ArpadZinzani, Pier LuigiHuettmann, AndreasTrneny, MarekLe Gouill, StevenJagadeesh, DeepaFriedberg, Jonathan W.Little, MeredithDong, CassieFanale, MichelleFenton, KeenanSavage, Kerry J.
DOI
10.1038/s41408-025-01329-2
발행일
2025-08
유형
Letter
저널명
Blood Cancer Journal
15
1